Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 8/2006

01-09-2006

Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy

Authors: Akinori Rokuhara, Akihiro Matsumoto, Eiji Tanaka, Takeji Umemura, Kaname Yoshizawa, Tatsuji Kimura, Noboru Maki, Kendo Kiyosawa

Published in: Journal of Gastroenterology | Issue 8/2006

Login to get access
Metadata
Title
Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy
Authors
Akinori Rokuhara
Akihiro Matsumoto
Eiji Tanaka
Takeji Umemura
Kaname Yoshizawa
Tatsuji Kimura
Noboru Maki
Kendo Kiyosawa
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 8/2006
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-006-1856-4

Other articles of this Issue 8/2006

Journal of Gastroenterology 8/2006 Go to the issue

Case report

Relapsing acute pancreatitis due to ampullary adenoma in a patient with familial adenomatous polyposis

OriginalPaper

Review of the pathological results of 2660 appendicectomy specimens

Editorial

Eupatilin has an antiapoptotic action on hepatocytes, in contrast to apoptotic actions on other cells

Letters to the editor

Immune complex of hepatitis C virus particles detected by immunogold electron microscopy

OriginalPaper

Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3

OriginalPaper

Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits